Wedbush lowered the firm’s price target on Xometry (XMTR) to $60 from $70 and keeps an Outperform rating on the shares. The firm notes Xometry reported strong Q4 results with revenue and adjusted EBITDA ahead of expectations. Q1 guidance was encouraging, with management anticipating revenue growth of 24.5% year-over-year at the midpoint, ahead of estimates by 240bps. Wedbush notes shares were down over 20%, likely reflecting uncertainty around the company’s leadership change and AI concerns permeating public markets.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XMTR:
- Xometry price target lowered to $55 from $64 at RBC Capital
- Xometry price target lowered to $65 from $75 at Citi
- Buy Rating Maintained on Xometry Amid Strong Momentum, Conservative 2026 Guidance, and Strategically Positive CEO Transition
- William Blair recommends buying Xometry on post-earnings weakness
- Xometry falls -20.3%